Tag: patient

– Filing based on pivotal Phase 3 VERITAC-2 clinical trial demonstrating statistically significant and clinically meaningful improvement in median progression-free survival versus fulvestrant –

-- Continued Progress on Regulatory Approvals and Global Commercialization of Fertility Portfolio --

ATLANTA, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced its financial results for the second quarter of 2025.

A personalised, root-cause approach that challenges one-size-fits-all physiotherapy.

WARREN, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced an update on institutional ownership of the Company’s outstanding common stock, as reported by institutional investment managers on Form 13F filed with the Securities and Exchange Commission (SEC).

Burlingame, CA, Aug. 08, 2025 (GLOBE NEWSWIRE) -- The global Medical Technology Platform Market is estimated to be valued at USD 31.59 Bn in 2025 and is expected to reach USD 67.26 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 11.4% from 2025 to 2032. The medical technology platform market is experiencing rapid growth, driven by the integration of advanced technologies such as artificial intelligence, cloud computing, Internet of Medical Things (IoMT), and big data analytics. These platforms enable seamless healthcare delivery through telemedicine, remote patient monitoring, diagnostics, and personalized treatment solutions. Trends such as interoperability, predictive analytics for disease management, and patient-centric digital ecosystems are reshaping the healthcare landscape. Rising demand for connected, data-driven care, coupled with regulatory support and the push for value-based healthcare, is positioning the medical technology platform market as a key driver of future medical innovation and efficiency.